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Abstract Non-fermentative Gram-negative bacilli are now
one of the most important causes of severe infections in
Polish hospitals. Acinetobacter species are serious concern
because of the high prevalence ofmulti-drug resistance among
strains. Resistance profiles for 53 Gram-negative non-fermen-
tative blood isolates were done. MLST was carried out using
44 strains representing the most commonly isolated species:
A. baumannii, P. aeruginosa, and S. maltophilia. MLST re-
vealed that all 22 A. baumannii belonged to sequence type
(ST) 2. The P. aeruginosa isolates belonged to 10 different
STs. Four S. maltophilia isolates matched STs present in the
database (ST4, ST15, ST116, ST142), seven isolates showing
novel sequence types. Among P. aeruginosa and S.
maltophilia PFGE confirmed the genetical variety of strains.
Keywords Non-fermentative gram negative bacilli .
Bloodstream infection .MLST
Introduction
Infections, including bloodstream infections (BSI), caused by
non-fermentative Gram-negative bacteria are an emerging
problem in hospital settings, especially when caused by
multi-drug resistant (MDR) strains. The most commonly
isolated bacterial species are Acinetobacter baumannii
and Pseudomonas aeruginosa, with infections caused by
these species significantly outnumbering those caused by
other species such as Stenotrophomonas maltophilia.
Gram-negative bacteria are ubiquitous in the environ-
ment, but MDR A.baumannii adapts extremely quickly
to the hospital environment, and may cause outbreaks
(Wybo et al. 2007; Baang et al. 2012).
According to World Health Organization data, the
number of BSI caused by P. aeruginosa is increasing:
from 2009 to 2010 about 3.8% of BSI were caused by
P. aeruginosa, compared with about 3% from 1992 to
1997. Interestingly, 17% of pneumonia cases were caused
by P. aeruginosa in 2010, which was lower than in 1997
(21%) (Sievert et al. 2013). In addition, the mortality rate
for BSI caused by P. aeruginosa is quite high (about
30%), with P. aeruginosa being identified as a risk factor
for mortality in BSI cases (Pena et al. 2012a, b). In
China, the mortality rate is even higher, with about
40% of BSI caused by P. aeruginosa resulting in death
(Kang et al. 2003).
In a national survey of hospital laboratories, A. baumannii
infections accounted for only 1.3% of healthcare-associated
BSI (Wisplinghoff et al. 2004). However, other studies have
indicated an increase in the number of reported BSI caused by
A. baumannii, such as one study in patients from military
medical facilities in Iraq, Kuwait, and Afghanistan (Centers
for Disease Control and Prevention 2004). S. maltophilia is
naturally resistant to many antimicrobial agents, including
carbapenems, what may be the cause of treatment failure in
infections linked to this bacterium. Therefore, the overall mor-
tality rate of S. maltophilia BSI is very high, and ranges from
21% to 50% (Araoka et al. 2010; Senol et al. 2002; Garazi
et al. 2012). One study found that risk factors associated with
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S. maltophilia bacteremia included use of carbapenems and
antipseudomonal cephalosporins, and the isolation of
S. maltophilia within 30 days of treatment (Hotta et al. 2014).
Data from a Spanish national survey conducted in 2012
showed that about 20% of bacterial strains isolated from BSI
are MDR, 20% of which are carbapenem-resistant (Pena et al.
2012a, b). Therefore, the aim of this study was to analyze the
molecular epidemiology and resistance profiles of Gram-
negative non-fermentative bacteria isolated from patients hos-
pitalized as a result of BSI in southern Poland, with a partic-
ular focus on multi-locus sequence typing (MLST).
Material and methods
Study population
Consecutive, non-repetitive non-fermentative Gram-negative
bacillus isolates from hospitalized patients with BSI were col-
lected from seven hospitals in southern Poland. Patients were
hospitalized in three intensive care units, four internal, and
three nephrology or urology wards. Isolates were received
by the Department of Microbiology at Jagiellonian
University Medical College, and were collected in collabora-
tion with two other laboratories 1st January and 31st
December, 2013. Patient information, including age, sex,
and place of hospitalization, was also collected.
This work was approved by the Bioethics Committee of
Jagiellonian University Medical College (no. KBET/312/B/
2012 and KBET/362/B/2012). All data were anonymized pri-
or to analysis.
Bacterial isolates
Specimens were collected from patients at the onset of symp-
toms of infection. During the study period, microbiological
examination was performed on 1721 blood samples, with a
total of 53 Gram-negative non-fermentative isolates tested.
Identification of microorganisms was performed using the
semi-automated Phoenix system (Becton-Dickinson
Diagnostic System, France) according to standard methods.
Susceptibility testing
Susceptibility testing was performed using the semi-
automated Phoenix NMIC/ID-204 system (Becton-
Dickinson) according to the manufacturer’s instructions.
Antimicrobial susceptibility was assessed according to the
current European Committee on Antimicrobial Susceptibility
Testing guidelines (EUCAST clinical breakpoint tables v. 5.0;
http://www.eucast.org/clinical_breakpoints/, accessed 25.09.
2015) and the results were considered as resistant (R) and
susceptible (S). Resistant and intermediate strains were
grouped together as drug resistant. For ampicillin-sulbactam
and tetracycline, antimicrobial susceptibility was assessed ac-
cording to the Clinical Laboratory Standards Institute
guidelines.
For P.aeruginosa 13 antimicrobials were tested (gentami-
cin, tobramycin, amikacin, netilmicin, imipenem,
meropenem, ciprofloxacin, levofloxacin, piperacillin/tazobac-
tam, ceftazidime, cefepime, aztreonam, colistin). For
A.baumannii 15 antimicrobials were tested (gentamicin,
tobramycin, amikacin, netilmicin, imipenem, meropenem,
ciprofloxacin, levofloxacin, piperacillin/tazobactam, ceftazi-
dime, cefepime, trimethoprim/sulfamethoxazole, ampicillin/
sulbactam, colistin, tetracycline). For S. maltophilia only
trimethoprim-sulfamethoxazole and ceftazidime were tested.
(Supplementary Table S1).
Different patterns of resistance, including extensively drug
resistant (XDR) and multi-drug resistant (MDR) were defined
according to Magiorakos et al. (2012): (1) bacteria non-
susceptible to at least one agent in three or more antimicrobial
categories were considered as MDR strains; (2) bacteria non-
susceptible to at least one agent in all antimicrobial categories,
except two or fewer categories were considered as XDR
strains.
Multi-locus sequence typing
MLSTwas carried out as described previously using 44 strains
representing the three most commonly isolated species:
A.baumannii (Diancourt et al. 2010), P.aeruginosa (Curran
et al. 2004), and S.maltophilia (Kaiser et al. 2009).
Sequencing was performed by Genomed SA (Warsaw,
Poland), and the resulting sequences were analyzed using
ChromasPro 1.4 software (Technelysium Pty Ltd.,
Australia). MLST data were then compared with the database
(http://pubmlst.org) to identify sequence types.
Pulsed field gel-electrophoresis
Analysis of the genetic similarity between P. aeruginosa
strains or between S. maltophilia strains (separately within
species) was performed using pulsed field gel electrophoresis
(PFGE) in accordance with a previously published protocol
(Shueh et al. 2013). Restriction enzyme digestion of
P. aeruginosa strains was performed with 25 U of Spe I en-
zyme in Tango buffer and S. maltophilia strains were digested
by Xba I enzyme in Tango buffer (Thermo-Scientific, USA).
Electrophoresis was conducted in a CHEFIII PFGE unit ap-
plying the parameters: for P.aeruginosa- initial pulse 1 s, final
pulse 35 s, run time 23 h, voltage 6 V/cm; for S.maltophilia-
block 1: initial pulse 1 s, final pulse 15 s, run time 10 h,
voltage 6 V/cm, block2: initial pulse 15 s, final pulse 60s,
run time 11 h, voltage 6 V/cm. Gel Compar II 6.5
(AppliedMaths, Belgium) was used for cluster analysis using
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the Dice coefficient and unweighted pair group method with
arithmetic mean.
Isolates with more than 90% similarity were clustered to-
gether as identical.
Repetitive PCR (rep-PCR)
Epidemiological typing of A. baumannii strains from ICUs
was performed by repetitive-PCR typing using DiversiLab
system (bioMerieux, France) as previously described
(Chmielarczyk et al. 2016). Isolates that clustered ≥91.3%
were considered related. Results of A.baumannii typing were
already published.
Results
Of the 53 patients with BSI, 40 (74.1%) were men. The me-
dian age was 64 years (1st and 3rd quartile:40 and 75 years,
respectively). The majority of patients were hospitalized in
intensive care units (n = 30, 56.5%), followed by nephrology
or urology wards (n = 14, 26.5%) and internal medicine wards
(n = 9, 17.0%).
A. baumannii was the most frequently (n = 22, 41.5%),
fol lowed by P. aeruginosa (n = 11, 20.7%) and
S. maltophilia (n = 11, 20.7%). Other species identified at
much lower frequencies included Achromobacter
denitrificans (n = 5, 9.4%), Acinetobacter lwoffii (n = 1,
1.9%), Acinetobacter ursingii (n = 1, 1.9%), Comamonas
testosterone (n = 1, 1.9%), and Ochrobactrum anthropi
(n = 1, 1.9%). The prevalence rates of the non-fermentative
Gram-negative bacterial species in blood were: A. baumannii,
1.3%; P. aeruginosa, 0.6%; S. maltophilia, 0.6%; and others
(pooled), 0.4%. In addition, multiple pathogens were isolated
from the blood samples of five patients. These samples
contained: A.baumannii together with coagulase-negative
Staphylococcus; A.baumannii together with Enterococcus
faecium; A. ursingii together with S.maltophilia; S.maltophilia
together with coagulase-negative Staphylococcus; and
C. testosterone together with Achromobacter denitrificans.
The vast majority of A.baumannii isolates (n = 19, 86.3%)
were XDR, while the remaining isolates were MDR. Fourteen
A.baumannii strains (63.6%) were resistant to all tested anti-
biotics except colistin. Among the P. aeruginosa isolates, only
one was XDR, one was MDR, and all remaining isolates were
susceptible to the tested antimicrobials. All S.maltophilia iso-
lates were susceptible to sulfamethoxazole/trimethoprim and
resistant to ceftazidime. Detailed results of resistance are in
Supplementary Table S1.
MLST revealed that all 22 A.baumannii strains from the
BSI samples belonged to sequence type (ST) 2. Seventeen of
these isolates came from one hospital ward. The P.aeruginosa
isolates belonged to 10 different STs. Only four S.maltophilia
isolates matched STs present in the database (ST4, ST15,
ST116, ST142), with all other isolates showing novel se-
quence types. Five of these isolates had an identical allele
pattern, four of which were isolated from patients on a single
unit (Table 1). The detailed nucleotide sequences that were
obtained by MLST, are a part of the Supplementary Material.
PFGE typing of P.aeruginosa strains has shown very high
heterogenity among the strains. Pulsotypes showed similarity
between 50 and 65%. Two strains of P. aeruginosa with the
same sequence type (ST253) were characterized by different
pulsotypes (Fig. 1). It was different in case of S.maltophilia
strains, where 5 strains showed similarity at the level of 90%.
These strains had also the same allele pattern in the MLST
method and, what is more, four of them were derived from the
patients hospitalized on the same single unit (Fig. 2).
In rep-PCR sixteen strains of A.baumannii (72.7%)
belonged to European clone II (EUII) assigned, three strains
belonged to other clones and 3 strains have not been tested
(only strains from ICU were been tested). This data was pre-
viously published (Chmielarczyk et al. 2016).
Discussion
The prevalence of BSI caused by non-fermentative Gram-neg-
ative bacilli has increased in recent years (Rattanaumpawan
et al. 2013). A. baumannii and P. aeruginosa remain the pre-
dominant species, but other species are now frequently being
identified (Livermore et al. 2008; Vidal et al. 2003). This may
be the result of better identification techniques, or changes in
the local epidemiology in the hospital wards.
The dissemination of carbapenem-resistant A. baumannii
in hospitals worldwide is understood as a clonal process: the
strains are transmitted through patients and it may cause out-
breaks (Munoz-Price et al. 2010). The remarkably high prev-
alence of A.baumannii is partly the result of clonal spreading,
as all isolated strains in the current study belonged to ST2. We
have previously confirmed (by rep-PCR with DiversiLab sys-
tem) the dominance in southern Poland of international clone
2,which is ubiquitous in Europe (Chmielarczyk et al. 2016).
Epidemiological studies are important for monitoring XDR
A. baumannii strains. Apart from such typing methods as
MLST and rep-PCR, whole genome sequencing (WGS) is
the promising technique for strain typing and outbreak inves-
tigation. WGS seems to be more discriminatory than band-
based techniques however still is very expensive, and requires
an additional person skilled in bioinformatics (Fitzpatrick
et al. 2016).
Of serious concern is the phenotype of this our clone,
with strains of this type mainly only susceptible to colistin.
Unfortunately, we have no data regarding the mortality
rates of patients, nor the use of central venous catheters,
which is needed for more in-depth study of XDR
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A. baumannii. In the ICU the most frequent empirically
prescribed antibiotics are carbapenems. The major limita-
tion of using tygecycline in treatment of BSIs is the low
concentration that this substance achieves in serum.
Therefore, the most adequate in salvage therapy in the case
of XDR A.baumannii or P.aeruginosa would be colistin in
Fig. 1 Pulsed-field gel electrophoresis dendrogram of Stenotrophomonas
maltophilia strains generated by Gel Compar II software (Dice coefficient,
tolerance 0%, optimization 1%) together with sequence types (ST)
Figure 2. Pulsed-field gel electrophoresis dendrogram of Pseudomonas
aeruginosa strains generated by Gel Compar II software (Dice
coefficient, tolerance 0%, optimization 1%) together with sequence
types (ST).
Table 1 Alleles and sequence types Gram negative non-fermentative strains
Species and strain number Ward Alleles Sequence type (ST)
Acinetobacter baumannii cpn60 fusA gltA pyrG recA rplB rpoB
17 isolated strains ICU1 2 2 2 2 2 2 2 2
2 isolated strains ICU2 2 2 2 2 2 2 2 2
No. 53 Urology1 2 2 2 2 2 2 2 2
No. 480 Urology2 2 2 2 2 2 2 2 2
No. 835 Internal1 2 2 2 2 2 2 2 2
Pseudomonas aeruginosa acs aro gua mut nuo pps trp
No. 17 Urology1 3 104 4 36 71 44 53 27
No. 253 Urology1 38 11 3 13 1 2 4 235
No. 408 ICU1 17 5 12 3 14 4 7 244
No. 429 ICU1 114 73 32 3 4 50 1 396
No. 520 Internal2 22 20 11 3 3 3 7 348
No. 725 ICU1 31 5 57 13 1 40 3 137
No. 764 ICU1 28 3 94 13 4 1 10 644
No. 779 ICU1 14 5 10 7 4 13 7 260
No. 783 ICU1 4 4 12 16 1 6 3 253
No. 786 ICU1 4 4 12 16 1 6 3 253
No. 892 ICU1 17 3 5 4 4 4 3 966
Stenotrophomonas maltophilia atpD gapA guaA mutM nuoD ppsA recA
No. 3 Urology1 76 68 7 7 80 93 74 novel 1
No. 14 Internal3 76 68 7 7 80 93 74
No. 19 Urology1 76 68 7 7 80 93 74
No. 22 Urology1 76 68 7 7 80 93 74
No. 25 ICU3 80 89 43 73 72 98 79 142
No. 129 Urology1 76 68 105 67 80 93 74 novel 2
No. 318 Urology1 3 1 84 58 25 82 6 116
No. 327 Urology1 76 68 7 7 80 93 74 novel 1
No. 435 ICU1 6 1 39 19 76 33 78 novel 3
No. 6840 ICU1 1 4 7 7 28 19 6 4
No. 11865 ICU1 10 29 21 21 32 32 10 15
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monotherapy or in combination therapy with other agents
(Martis et al. 2014; Dimopoulos et al. 2015).
P. aeruginosawas isolated from BSI in the current study at
a frequency only half that of A. baumannii, which is not con-
sistent with other studies: P. aeruginosa is generally more
common than A. baumannii (Picot-Guéraud et al. 2015;
Sligl et al. 2015; Hotta et al. 2014). There was also a higher
level of diversity among the P. aeruginosa isolates, with only
two isolates showing the same ST (ST253), both of which
were isolated from patients hospitalized on the same ward.
Only one P. aeruginosa isolate belonged to globally dissemi-
nated XDR ST235 clone type. The PFGE method confirmed
the genetic diversity among P. aeruginosa strains.
Our study also identified a relatively high number of
S. maltophilia (20.7% of the total number of isolates) and
A. denitrificans (9.4%) isolates. These prevalence rates were
much higher than in a previous study by Rattanaumpawan
et al. (5.4% and 0%, respectively), but similar to results ob-
tained by Hotta et al. (S. maltophilia prevalence of 18.6%).
Five of the S. maltophilia isolates had the same novel ST, and
four of these isolates came from the same ward. What is more,
they were characterized by identical pulsotypes according to
PFGE method. We therefore assume that horizontal transmis-
sion was responsible for these infections. All S. maltophilia
isolates were susceptible to sulfamethoxazole/trimethoprim,
but some previous studies have suggested that levofloxacin
should be used as an alternative treatment of BSI caused by
S. maltophilia (Cho et al. 2014).
Interestingly, while other Gram-negative bacillus species
were identified as the cause of BSI in the current study, none
of these isolates were MDR. A. denitrificans rarely causes
infectious disease in humans, and is mainly associated with
immunocompromised patients.
An outbreak caused by C. testosteroni affecting hemato-
logical patients resulted from contamination of a disinfectant
dispenser in a hospital in France in 2007 have been reported
(Siebor et al. 2007), but no other infectious outbreaks caused
by C. testosteroni have been reported. In addition, there is
currently no MLST protocol for this species.
Analysis of the local epidemiology and antimicrobial sus-
ceptibility patterns of bacteria causing BSI may aid in the
development of empiric therapy guidelines, infection surveil-
lance programs, and improved patient outcomes.
Conclusions
Non-fermentative Gram-negative bacilli are now one of the
most important causes of severe infections in Polish hospitals.
Acinetobacter species are more commonly isolated from BSI
in Poland than in other countries, which is of serious concern
because of the high prevalence ofmulti-drug resistance among
A. baumannii strains. Treatment options are severely limited
for these bacteria, which are a known risk factor for increased
patient mortality. The MLST technique (as well as rep-PCR)
allows confirmation of horizontal transfer of Acinetobacter
strains, and may aid in the identification of a common source
of infection. Among P. aeruginosa, both typing methods
(MLST and PFGE) showed the genetical variety of strains.
While there is no onemethod guaranteed to reduce the number
of infections caused by Gram-negative bacilli, in the case of
Acinetobacter, appropriate infection control and hand hygiene
may be effective.
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